Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Intermediate I. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113307778A reveals a novel Mo-Cu co-catalyzed route for 3-trifluoromethyl-1,2,4-triazoles, offering mild conditions and high efficiency for reliable pharmaceutical intermediate supply.
Patent CN108314642B details a metal-free iodine-catalyzed route to 2-methylpyridines using triethylamine, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN111233852A discloses a benzoisofuran-based ligand for asymmetric fluorination, offering mild conditions and high stereoselectivity for pharmaceutical intermediate manufacturing.
Patent CN114478375A reveals a novel Pd-catalyzed route to 3-alkenyl quinolin-2(1H)ones using allyl aryl ethers, offering safer carbonylation and cost reduction in API manufacturing.
Patent CN114163436A details a Pd-catalyzed route for indolizine-diarylmethanes. Delivers high-purity API intermediates with scalable cost reduction strategies.
Patent CN115353511A details a safe, multi-component synthesis of carbonyl-bridged biheterocycles using formic acid as a CO source, offering significant cost reduction in API manufacturing.
Novel organocatalytic synthesis of axially chiral 1-aryl indoles via spirophosphoric acid. Offers mild conditions and high enantioselectivity for glioma drug development.
Patent CN115960142A discloses a one-pot synthesis of osmium heterocycles enabling high-yield hydrosilylation under air, offering cost-effective solutions for fine chemical manufacturing.
Patent CN112694430B reveals a novel Pd-catalyzed bis-carbonylation route for 1,5-dihydro-2H-pyrrole-2-one compounds, offering high efficiency and substrate compatibility for pharmaceutical manufacturing.
Novel carbonylation route for pyrrol-2-one scaffolds offers high efficiency and substrate compatibility for pharmaceutical manufacturing.
Efficient Pd-catalyzed synthesis of 2-pyridinecarboxamide diaryl ketones. High purity pharma intermediates with scalable routes for cost-effective manufacturing.
Patent CN114773242A reveals a novel nickel-catalyzed route for alpha,beta-unsaturated thioesters, offering significant cost reduction and supply chain reliability for pharma intermediates.
Patent CN113683595B reveals sulfur-promoted synthesis for high-purity triazole intermediates. Enables cost reduction and scalable supply chain for global pharmaceutical manufacturing.
Patent CN113121462B reveals a metal-free, azide-safe route for 5-trifluoromethyl-1,2,3-triazoles, offering cost reduction in API manufacturing and scalable supply.
Patent CN113735778B reveals efficient Ag2O promoted synthesis. Delivers high-purity pharmaceutical intermediates with significant cost reduction and supply chain reliability.
Patent CN107663149A details a novel selenium-catalyzed route for phenanthrenequinone. Offers cost reduction in pharmaceutical intermediates manufacturing and high-purity output.
Patent CN112126941B reveals a green electrochemical route for 10-hydroxyphenanthrene derivatives, offering cost-effective and scalable pharmaceutical intermediate manufacturing solutions.
Novel Rose Bengal catalyzed method for alpha-indole glycine derivatives offers green, scalable production for pharmaceutical intermediates.
Novel iodine-promoted synthesis of 5-trifluoromethyl-1,2,4-triazoles. Cost-effective, scalable route for API intermediates without heavy metals.
Patent CN112239456B details a safe Pd-catalyzed carbonylation route for 2,3-dihydroquinolones, offering reliable pharmaceutical intermediate supply and reduced operational risks.